Roche Precision Medicine Article Features Iya Khalil

Dr. Iya Khalil, GNS chief commercial officer and co-founder, gave her perspectives on the application of machine learning to clinical trials in “Partnering in the Digital Era“, an article published by Roche this week. The precision medicine piece focuses on how collaborations between healthcare and technology companies are driving the future of healthcare and features […]

Neo.Life features Iya Khalil in 2018 Biotech Breakthroughs and Big Ideas

In this January article, Neo.Life profiles the biggest biotech breakthroughs and big ideas for 2018, including thoughts from Iya Khalil, GNS co-founder and chief commercial officer. Iya speaks to the proliferation of emerging -omic data and how advances in artificial intelligence, and specifically causal machine learning, can use this data to drive better health outcomes […]

GNS Healthcare Uses Causal AI to Discover Which Multiple Myeloma Patients Will Have Progression Free Survival Benefit from Stem Cell Treatments

Details of the Discovery Leveraging the Multiple Myeloma Research Foundation CoMMpass Study Presented at 59th Annual ASH Meeting CAMBRIDGE, Mass.– December 12, 2017 – GNS Healthcare (GNS), a leading precision medicine company, together with the Multiple Myeloma Research Foundation (MMRF), have discovered a biomarker that identifies which multiple myeloma patients will benefit from stem cell transplantation. […]